{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:48:00Z","timestamp":1765176480441},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of this study was to report the long-term clinical outcomes of patients who received stereotactic body radiotherapy (SBRT) as a boost treatment for head and neck cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Between March 2004 and July 2007, 26 patients with locally advanced, medically inoperable head and neck cancer or gross residual tumors in close proximity to critical structures following head and neck surgery were treated with SBRT as a boost treatment. All patients were initially treated with standard external beam radiotherapy (EBRT). SBRT boost was prescribed to the median 80% isodose line with a median dose of 21 (range 10\u201325) Gy in 2\u20135 (median, 5) fractions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median follow-up after SBRT was 56 (range 27.6\u2009\u2212\u200980.2) months. The distribution of treatment sites in 26 patients was as follows: the nasopharynx, including the base of the skull in 10 (38.5%); nasal cavity or paranasal sinus in 8 (30.8%); periorbit in 4 (15.4%); tongue in 3 (11.5%); and oropharyngeal wall in 1 (3.8%). The median EBRT dose before SBRT was 50.4\u2009Gy (range 39.6\u2009\u2212\u200970.2). The major response rate was 100% with 21 (80.8%) complete responses (CR). Severe (grade\u2009\u2265\u20093) late toxicities developed in 9 (34.6%) patients, and SBRT boost volume was a significant parameter predicting severe late complication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The present study demonstrates that a modern SBRT boost is a highly efficient tool for local tumor control. However, we observed a high frequency of serious late complications. More optimized dose fractionation schedule and patient selection are required to achieve excellent local control without significant late morbidities in head and neck boost treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-7-85","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T17:54:54Z","timestamp":1340128494000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment"],"prefix":"10.1186","volume":"7","author":[{"given":"Dong Soo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Sil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seok","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Hyun","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Nam","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Hyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Lyoung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Seok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","volume":"20","author":"AT Chan","year":"2002","unstructured":"Chan AT, Teo PM, Ngan RK, et al: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 2002, 20: 2038-2044. 10.1200\/JCO.2002.08.149.","journal-title":"J Clin Oncol"},{"key":"585_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-6-28","volume":"6","author":"W Budach","year":"2006","unstructured":"Budach W, Hehr T, Budach V, Belka C, Dietz K: A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006, 6: 28-10.1186\/1471-2407-6-28.","journal-title":"BMC Cancer"},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.ijrobp.2003.09.004","volume":"58","author":"DM Brizel","year":"2004","unstructured":"Brizel DM, Prosnitz RG, Hunter S, et al: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004, 58: 1418-1423. 10.1016\/j.ijrobp.2003.09.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"585_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006, 354: 567-578. 10.1056\/NEJMoa053422.","journal-title":"N Engl J Med"},{"key":"585_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/1097-0142(19850915)56:6<1242::AID-CNCR2820560603>3.0.CO;2-Z","volume":"56","author":"WK Hong","year":"1985","unstructured":"Hong WK, Bromer RH, Amato DA, et al: Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer. 1985, 56: 1242-1245. 10.1002\/1097-0142(19850915)56:6<1242::AID-CNCR2820560603>3.0.CO;2-Z.","journal-title":"Cancer"},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00001622-200205000-00013","volume":"14","author":"MC Garofalo","year":"2002","unstructured":"Garofalo MC, Haraf DJ: Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol. 2002, 14: 330-333. 10.1097\/00001622-200205000-00013.","journal-title":"Curr Opin Oncol"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/1097-0142(19820915)50:6<1042::AID-CNCR2820500604>3.0.CO;2-Y","volume":"50","author":"JE Marks","year":"1982","unstructured":"Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA: Dose\u2013response analysis for nasopharyngeal carcinoma: An historical perspective. Cancer. 1982, 50: 1042-1050. 10.1002\/1097-0142(19820915)50:6<1042::AID-CNCR2820500604>3.0.CO;2-Y.","journal-title":"Cancer"},{"key":"585_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clon.2006.02.009","volume":"18","author":"KA Dinshaw","year":"2006","unstructured":"Dinshaw KA, Agarwal JP, Ghosh-Laskar S, Gupta T, Shrivastava SK: Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors. Clin Oncol (R Coll Radiol). 2006, 18: 383-389. 10.1016\/j.clon.2006.02.009.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0360-3016(03)00117-2","volume":"56","author":"QT Le","year":"2003","unstructured":"Le QT, Tate D, Koong A, et al: Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003, 56: 1046-1054. 10.1016\/S0360-3016(03)00117-2.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"585_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ijrobp.2007.10.027","volume":"71","author":"W Hara","year":"2008","unstructured":"Hara W, Loo BW, Goffinet DR, et al: Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008, 71: 393-400. 10.1016\/j.ijrobp.2007.10.027.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"585_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1748-717X-5-51","volume":"5","author":"K Kawaguchi","year":"2010","unstructured":"Kawaguchi K, Sato K, Horie A, et al: Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol. 2010, 5: 51-10.1186\/1748-717X-5-51.","journal-title":"Radiat Oncol"},{"key":"585_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1748-717X-6-98","volume":"6","author":"H Yamazaki","year":"2011","unstructured":"Yamazaki H, Kodani N, Ogita M, Sato K, Himei K: Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy. Radiat Oncol. 2011, 6: 98-10.1186\/1748-717X-6-98.","journal-title":"Radiat Oncol"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, et al: Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010, 76: S3-S9. 10.1016\/j.ijrobp.2009.09.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000061211","volume":"33","author":"J Debus","year":"1999","unstructured":"Debus J, Hug EB, Liebsch NJ, et al: Dose volume tolerance of the brainstem after high-dose radiotherapy. Front Radiat Ther Oncol. 1999, 33: 305-314.","journal-title":"Front Radiat Ther Oncol"},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0167-8140(94)90005-1","volume":"30","author":"GL Jiang","year":"1994","unstructured":"Jiang GL, Tucker SL, Guttenberger R, et al: Radiation-induced injury to the visual pathway. Radiother Oncol. 1994, 30: 17-25. 10.1016\/0167-8140(94)90005-1.","journal-title":"Radiother Oncol"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","volume":"18","author":"JP Kirkpatrick","year":"2008","unstructured":"Kirkpatrick JP, Meyer JJ, Marks LB: The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008, 18: 240-243. 10.1016\/j.semradonc.2008.04.005.","journal-title":"Semin Radiat Oncol"},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","volume":"18","author":"DJ Brenner","year":"2008","unstructured":"Brenner DJ: The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol. 2008, 18: 234-239. 10.1016\/j.semradonc.2008.04.004.","journal-title":"Semin Radiat Oncol"},{"key":"585_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0167-8140(91)90106-Q","volume":"20","author":"GH Fletcher","year":"1991","unstructured":"Fletcher GH: Hypofractionation: lessons from complications. Radiother Oncol. 1991, 20: 10-15. 10.1016\/0167-8140(91)90106-Q.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:27:51Z","timestamp":1630524471000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-85","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]},"assertion":[{"value":"24 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"85"}}